DANIEL JOHNSON: Open Payments
NPI 1124199690 · LEBANON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 30 payments from 14 companies in 2025. Trend: 2023 $395 · 2024 $16 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $118 |
| Novo Nordisk Inc | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| ABBVIE INC. | 3 | $49 |
| Abbott Laboratories | 2 | $40 |
| Dexcom, Inc. | 2 | $37 |
| ACADIA Pharmaceuticals Inc | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| PFIZER INC. | 2 | $32 |
| Radius Health, Inc. | 1 | $24 |
Products named: CAPLYTA, Ozempic, FREESTYLE LIBRE, Dexcom G6 Transmitter, DAYBUE, GARDASIL 9, NURTEC ODT, Tymlos.
Industry payments across MO — which companies pay providers there.
